Literature DB >> 12394900

Respiratory dysfunction in patients with chronic-onset cervical myelopathy.

Tatsuya Ishibe1, Shinobu Takahashi.   

Abstract

STUDY
DESIGN: A retrospective study. OBJECTIVE To clarify the characteristics of respiratory dysfunction associated with chronic-onset cervical myelopathy. SUMMARY OF BACKGROUND DATA: In acute cervical cord injury, respiratory dysfunction, especially vital capacity (VC), is impaired, which causes respiratory complications. No comprehensive study has been published about respiratory dysfunction in patients with chronic-onset myelopathy.
METHODS: Eighty-four consecutive patients without history of respiratory disease who underwent surgery for cervical myelopathy were studied. The control group consisted of 84 age-matched patients with lumbar degenerative diseases. Parameters of spirometry, arterial blood gas, height of the diaphragm, and the score for neurologic impairment were analyzed before and after surgery.
RESULTS: Percent VC (%VC) was significantly lower in the study group than in the control group. In patients with cranial cord lesions and multilevel cord lesions, %VC was lower than in those with a caudal lesion and a single-level lesion, respectively. Percent VC correlated with the preoperative neurologic score in the study group. In patients having the lesion at or above C4, %VC improved after surgery, whereas in those with a lower lesion, %VC had not decreased before surgery, and no further improvement was obtained.
CONCLUSIONS: In patients with chronic-onset cervical myelopathy, %VC significantly decreases when they have more cranial or multilevel lesions. Percent VC also correlates with the preoperative neurologic score and improves with surgical treatment in patients with more cranial cord lesions. Respiratory dysfunction should be taken into consideration as a part of neurologic impairment in chronic-onset cervical myelopathy.

Entities:  

Mesh:

Year:  2002        PMID: 12394900     DOI: 10.1097/00007632-200210150-00010

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  8 in total

1.  Association Between Diaphragmatic Paralysis and Ipsilateral Cervical Spondylosis on MRI.

Authors:  Sarah L O'Beirne; J Levi Chazen; Joshua Cornman-Homonoff; Bridget T Carey; Brian D Gelbman
Journal:  Lung       Date:  2019-09-18       Impact factor: 2.584

Review 2.  [Cervical myelopathy as a complication of rheumatoid arthritis].

Authors:  A C Arlt; J Steinmetz
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

3.  Dyspnea as the Presenting Symptom of Cervical Spondylotic Myelopathy.

Authors:  Elizabeth Yu; Neil Romero; Troy Miles; Stephanie L Hsu; Dimitriy Kondrashov
Journal:  Surg J (N Y)       Date:  2016-12-14

4.  Resolution of Right Hemidiaphragm Paralysis following Cervical Foraminotomies.

Authors:  Neal Singleton; Matthew Bowman; David Bartle
Journal:  Case Rep Orthop       Date:  2018-03-04

5.  Restrictive ventilatory impairment improved by laminoplasty for ossification of the posterior longitudinal ligament.

Authors:  Takashi Nishida; Takashi Ishiguro; Chie Ota; Yotaro Takaku; Naho Kagiyama; Kazuyoshi Kurashima; Noboru Takayanagi
Journal:  Clin Case Rep       Date:  2018-12-27

6.  Hemidiaphragmatic Paralysis Due to Cervical Spondylosis: A Case Report.

Authors:  Hiroaki Manabe; Toshinori Sakai; Fumitake Tezuka; Kazuta Yamashita; Yoichiro Takata; Takashi Chikawa; Koichi Sairyo
Journal:  Spine Surg Relat Res       Date:  2018-05-29

7.  Life expectancy after cervical laminoplasty-Causes of the fatal prognosis at the early stage (within 5 years).

Authors:  Yoshiharu Kawaguchi; Masato Nakano; Taketoshi Yasuda; Shoji Seki; Kayo Suzuki; Yasuhito Yahara; Hiroto Makino; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Spine Surg Relat Res       Date:  2017-11-27

8.  Dyspnea Associated with Cervical Spondylotic Radiculopathy: A Case Report and Review of Literatures.

Authors:  Soichiro Takamiya; Toshitaka Seki; Kazuyoshi Yamazaki; Ikuma Echizenya
Journal:  NMC Case Rep J       Date:  2021-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.